Active Ingredient: PAZOPANIB HYDROCHLORIDE
Proprietary Name: VOTRIENT
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022465
Product Number: 002
Approval Date: Oct 19, 2009
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information